



Currents issues in cardiorespiratory care of 
patients with post-polio syndrome
Tópicos atuais no tratamento cardiorrespiratório de pacientes com síndrome 
pós-poliomielite
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Neuromuscular diseases (NMDs) can affect anyone at 
any time. They cause muscle weakness that can affect the 
heart, breathing, coughing, swallowing, speech, and limbs 
muscles, all of which cause disability and compromise the 
quality of life. Previous acute poliomyelitis (PAP) can be de-
fined as an endemic human disease caused by an enterovirus 
of worldwide distribution, which compromises the anterior 
horn cells of the spinal cord1,2.
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AbstrACt
Post-polio syndrome (PPS) is a condition that affects polio survivors years after recovery from an initial acute attack of the poliomyelitis 
virus. Most often, polio survivors experience a gradual new weakening in muscles that were previously affected by the polio infection. 
The actual incidence of cardiovascular diseases (CVDs) in individuals suffering from PPS is not known. However, there is a reason to suspect 
that individuals with PPS might be at increased risk. Method: A search for papers was made in the databases Bireme, Scielo and Pubmed 
with the following keywords: post polio syndrome, cardiorespiratory and rehabilitation in English, French and Spanish languages. Although 
we targeted only seek current studies on the topic in question, only the relevant (double-blind, randomized-controlled and consensus 
articles) were considered. Results and Discussion: Certain features of PPS such as generalized fatigue, generalized and specific muscle 
weakness, joint and/or muscle pain may result in physical inactivity deconditioning obesity and dyslipidemia. Respiratory difficulties are 
common and may result in hypoxemia. Conclusion: Only when evaluated and treated promptly, somE patients can obtain the full benefits of 
the use of respiratory muscles aids as far as quality of life is concerned.
Keywords: postpoliomyelitis syndrome; respiration disorders; rehabilitation.
resumo
Síndrome pós-polio (SPP) é uma condição que afeta sobreviventes da poliomielite aguda (PAA), anos após a recuperação de um ataque agudo 
inicial do vírus. Na maioria das vezes, os sobreviventes da polio começam a apresentar nova paresia gradual nos músculos que foram previamente 
afetados pela infecção. A incidência real de doenças cardiovasculares (DCV) em indivíduos que sofrem de SPP não é conhecida. Entretanto, há 
indícios para suspeitar de que sujeitos com SPP podem estar em maior risco. Método: Realizou-se uma busca de artigos nas bases de dados: 
Bireme, Scielo e Pubmed, utilizando as seguintes palavras-chave: síndrome pós-poliomielite, função cardiorrespiratória e reabilitação, nos idiomas 
Inglês, Francês e Espanhol. Embora tenhamos selecionado um número expressivo de artigos, somente foram considerados os duplo-cegos, 
randomizados-controlados, além de consensos.  Resultados e Discussão: Certas características da SPP, tais como fadiga muscular, paresia, 
dor muscular e/ou articulares podem resultar em descondicionamento por inatividade física, além de obesidade e dislipidemia. Dificuldades 
respiratórias são comuns e podem resultar em hipoxemia. Conclusão: Somente quando avaliados e tratados em tempo hábil, alguns pacientes 
são capazes de obter os benefícios do uso dos músculos respiratórios auxiliares em termos de qualidade de vida.
Palavras-chave: síndrome pós-poliomielite; transtornos respiratórios; reabilitação.
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A new framework for amyotrophy (Figures 1 and 2), 
unusual fatigue, joint problems, and pain – all with a progres-
sive characteristic, marks the post-polio syndrome (PPS). The 
prevalence of fatigue is remarkably high, and may contrib-
ute significantly to patients’ disability and a reduced quality 
of life. Other possible clinical presentations are the intoler-
ance to cold and cardiorespiratory problems, including sleep 
apnea. We emphasize that, although there is a broad range of 
signs and symptoms, its totality is not expressed in all those 
affected individuals1,2.
There is no particular electrodiagnostic test for PPS. 
Conventional electromyography is unable to distinguish 
reliably between stable post-polio patients and those 
with new weakness. However, clinical, electrophysiologi-
cal evaluation can be useful to document signs of pre-
vious motor neuron loss due to PAP, and for excluding 
other neurological disorders. The PPS diagnosis is sup-
ported by new clinical findings and clinical, electrophysi-
ological evidence of PAP3.
Patients with PAP might have compromised lung func-
tion, irrespectively of shortness of breath. Risk factors such 
as ventilation at polio-onset and polio-onset after ten years of 
age can help predict those at risk of respiratory compromise. 
The measurement of respiratory muscle strength and maxi-
mal expiratory pressure (MEP) in particular, can augment 
the assessment of lung function in this population4.
sleep disturbAnCes
Sleep disorders are common in PPS patients5.Their in-
sidious nature may hamper the recognition of these distur-
bances by patients, family and caregivers6. A study reporting 
nine months of follow up of 21 post-polio syndrome patients 
was not able to prove significant difference of sleep quality 
between post-polio syndrome, non-post-polio syndrome and 
control groups7.
Among sleep disorders related to PPS, periodic limb 
movements (PLM) hypopnea and, specially, obstructive sleep 
apnea (OSA) are the most frequent5,6,8. Breathing disturbanc-
es seem to be moreusual during sleep of PPS patients than 
in general population8. There are some signs and symptoms 
that may alert to the under ventilation, such as: orthopnea, 
insomnia, anxiety about going to sleep, restless fragmented 
sleep, morning headaches and worsening mental status6.
Prospective study with 60 PPS patients showed that 
sleep abnormalities was prevalent in 78.3% of patients. 
Sleep efficiency decreased in 44 of the 60 patients, ranging 
from 67.4% (patients with OSA, using non-invasive venti-
lation) to 69.5% (patients not using non-invasive ventila-
tion). This inefficiency is assigned to more than 10 arousals 
per hour, seep-related disordered breathing, PLM, changes 
in the different sleep stages and muscle and/or joint pain. 
Polysomnographic examination demonstrated greater time 
Figure 1. Amyotrophy: posterior view of the left lower limb. Figure 2. Amyotrophy: Side view of the left lower limb.
576 Arq Neuropsiquiatr 2016;74(7):574-579
spent in superficial sleep than in deeper stages8.This occur-
rence may be credited to the impairment induced by po-
liovirus on reticular formation, an area known to mediate 
initiation of REM sleep8,9. The latencies of tone reduction 
(MTR), sawtooth waves (STW), and REM seemed to be 
meaningfully higher in the bulbar involvement9.
In case of OSA, BiPAP, respiratory physical therapy, as well 
as, flu vaccines are among the resources indicated6,8,10. These 
sleep disorders may contribute to a cardinal PPS symptom: 
fatigue5,8,11,12. Considering its importance, some approaches 
were tried to minimize its impact. Modafenil was not superi-
or to placebo in alleviating fatigue or improving quality of life 
in sample of 36 PPS patients13. However, controlled trial dem-
onstrated that transcranial direct current stimulation (tDCS) 
over the pre-motor areas for fifteen days improved sleep and 
fatigue symptoms in patients with PPS13.
Generalized fatigue, specific muscle weakness 
and joint and/or muscle pain may result in physical 
inactivity – deconditioning, obesity and dyslipidemia. PAP 
and PPS with respiratory difficulties may develop hypoxemia. 
Any of these circumstances – deconditioning, obesity, dyslip-
idemia and hypoxemia – may increase the risk for cardiovas-
cular disease14.The safety and the efficacy of training PPS and 
other NMDs patients were evaluated by some investigators. 
All of them found that a carefully designed exercise program, 
which avoided excessive muscle fatigue was able to provide 
positive results. In general, exercise has to be started very 
gradually and at a lower level, individually tailored to each’s 
physical status and individual needs. Care should be taken to 
avoid overuse. Nutritional counseling is also useful15,16.
pulmonAry funCtion And respirAtory CAre 
in post-polio syndrome
Pulmonary function (PFTs) related to the effects of 
age-of-onset of the disease has been exhaustively investigat-
ed in PPS patients17,18. Many different tests and techniques 
have proved to be helpful in this regard, but disagreement on 
how best to use these tests still exists. All this effort might be 
explained due to the difficulty to diagnose respiratory failure 
from PPS, especially if not suspected17,19.
Interestingly, Halstead and Rossi17 observed that in pa-
tients with PPS, impaired lung function is associated with the 
age-of-onset (progression for ten years or more), the need for 
mechanical ventilation during the acute phase of the disease, 
quadriparesis, and time of exposure to the disease. In another 
study, Lane et al.20 described an association between respira-
tory dysfunction and the presence of kyphoscoliosis or dia-
phragmatic paralysis.
Usually, PPS affects the same muscle groups that were af-
fected by the initial onset of the disease. Thus, if respirato-
ry insufficiency was not a feature of the first presentation of 
polio, it is relatively unlikely to manifest itself during the PPS. 
However, the distribution and severity of respiratory muscle 
involvement in PPS patients is quite variable19.
Because of the variable distribution of paresis, there are 
some patients whose inspiratory and expiratory muscle 
weaknesses are roughly equal. In others, might predominate 
expiratory muscle weakness or inspiratory muscle weakness 
preferentially. There is a tendency for expiratory weakness 
exceed inspiratory weakness19,21.
The principal respiratory manifestation of PPS in the 
PFTs is a restrictive defect in ventilatory function. It happens 
due to the weakness of respiratory muscles, which are unable 
to generate either the intrathoracic vacuum necessary for full 
inspiration or the positive pressure needed for full expiration. 
Consequently, this leads to reductions in total lung capacity 
(TLC), vital capacity (VC), and maximal voluntary ventila-
tion (MVV). Additionally, Lira et al. observed that the MVV 
was approximately 27% lower in PPS patients compared to 
healthy controls (p = 0.0127). In the same study, however, 
the authors observed that the MVV values were within the 
normal range when compared with the predicted values for 
the Brazilian population22.
Similar to other neuromuscular diseases, the VC is lower 
than would be predicted from muscle weakness alone in PPS; 
this reduction is due in large part to reductions in the compli-
ance of the lung and chest wall. Residual volume is increased 
in some cases, not because of airway obstruction, but be-
cause PPS patients cannot overcome the outward recoil of 
the chest wall below residual functional capacity23.
The relative reduction of inspiratory capacity and expira-
tory reserve volume provide insight into the relative involve-
ment of inspiratory versus expiratory muscles, respectively. 
One application of spirometry that can provide helpful diag-
nostic information is comparing upright and supine VCs in 
PPS patients suspected of diaphragm weakness; a decline of 
25% or more when patients lie supine is considered an indi-
cator of significant weakness23.
Stiffness (reduced compliance) of the lungs and/or chest 
wall is another possible complication of PPS. The reduction 
in pulmonary compliance linked to the reduction in lung vol-
umes that is characteristic of the neuromuscular disease. 
The cause may be microatelectasis, reduced surface tension, 
alterations in the elastic fibers of the pulmonary interstitium, 
or a combination of one or more of these factors, each of 
which may result from habitually low lung volumes23.
Other late complications that may be related to PPS are 
chronic hypoventilation, alterations in central control of 
breathing, and sleep apnea syndrome. Studies of maximum 
respiratory pressures confirm that hypercapnia only devel-
ops when respiratory muscle strength is considerably re-
duced. Impairment of the upper respiratory system also can 
be an important but easily overlooked factor in PPS and war-
rants investigation when suspected24.
Some patients with PPS tend to breathe with a rapid, shal-
low pattern that compromises their ventilatory function by 
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increasing the ratio of dead space to vital volume. When the 
ventilatory load on the respiratory system is excessive about 
the ventilatory capacity, patients develop breathlessness, 
reduced exercise tolerance, and eventually ventilator failure24.
In addition to this, Weinberg et al. found that respiratory 
failure is the limiting factor for exercise in PPS patients with 
respiratory muscle dysfunction. According to these authors, 
the extent of lung disease is evident by blood gas values dur-
ing the exercise test, but not at rest18.
The respiratory care approach of post-polio syndrome pa-
tients follows the standard recommendations for patients 
with neuromuscular diseases with few particularities. As ex-
piratory muscle weakness is a common manifestation of ill-
ness, manually or mechanically assisted cough can be useful 
in selected patients aiming to prevent secretion retention25.
Moreover, when the inspiratory muscles are significantly 
compromised, other resources as breath-stacking technique, 
manual hyperinflation (using a resuscitator bag) and inter-
mittent positive pressure ventilators (volume or pressure 
controlled modes applied noninvasively by a mouthpiece or 
mask) can also be used to improve the inspiratory volume 
prior the forced expiratory maneuver26.
In severely compromised patients, both inspiratory and 
expiratory phases can be enhanced by using the mechan-
ically assisted cough, a device specially designed to im-
prove the cough in neuromuscular diseases. Patients with 
cough peak flow < 270 L/min should be considered eligible 
for cough peak flow augmentation techniques27. Likewise, 
the pulmonary expansion techniques are also advocated to 
maintain or improve pulmonary compliance and cough, and 
to diminish atelectasis28.
Some patients might benefit from noninvasive ventilation 
(NIV). Notably, those with clinical signs and symptoms of re-
spiratory failure and hypoventilation. Additionally, patients 
with some symptoms such as dyspnea on minor exertion or 
talking, orthopnea, frequent nocturnal awakenings, exces-
sive daytime sleepiness, daytime fatigue, morning headache, 
difficulty clearing secretions, apathy, poor appetite, poor con-
centration or memory) 29.
The NIV regimen usually starts with nighttime use and 
during the day as needed. When multiple hourly desatura-
tions below 95% occur, and home end tidal CO2 (EtCO2) 
measures over 50cm H2O, a trial of nocturnal NIV may help 
clear symptoms and normalize blood gases28.
Almost half of all patients with PPS present with some 
sleep disturbance, specifically fatigue and excessive daytime 
sleepiness, headaches, and restless legs syndrome (RLS)30. 
The main clinical findings are hypoventilation, apnea, and 
hypopnea associated with significant obstructions and de-
saturation reduced sleep efficiency due to prolonged sleep la-
tencies and high arousal indices8,31.
Although overnight EtCO2 provides valuable information 
concerning nocturnal hypoventilation, it is recommended 
that suspected sleep dysfunction in neuromuscular disorders 
be investigated with full-night in-laboratory polysomnogra-
phy (PSG)32. This tool is valuable both for the diagnosis and 
treatment adequacy, since it allows the noninvasive positive 
pressure titration to determine an effective level of noctur-
nal ventilatory support in patients with chronic alveolar hy-
poventilation, and/or sleep disturbances33.
CArdiologiC problems And rehAbilitAtion in 
post-polio syndrome
Cardiovascular diseases have a high incidence and prev-
alence, progressing to morbidity and mortality outcomes in 
the general population and should not be ignored in PPS. 
The frequent exposure to risk factors for cardiovascular dis-
eases, particularly for coronary heart disease (CHD) such as 
family history of CHD, obesity, diabetes mellitus, smoking, 
hypertension, increased LDL cholesterol, low HDL choles-
terol and dyslipidemia might increase the risk in PPS pa-
tients even further14,34.
An appropriate stratification of cardiovascular risk 
for PPS takes into consideration the use of global scores 
(Framingham, Münster Heart Study, Reynolds etc.). However, 
the use of coronary artery calcium (CAC) may be an excel-
lent alternative due to its good predictor power for coronary 
events evidenced in various multivariate analyses being cur-
rently an important tool for cardiovascular risk stratification, 
by subclinical atherosclerosis detection. As it does not re-
quire intravenous contrast, the performance of the CAC does 
not require fasting or any other type of preparation35.
Another relevant issue assessing the cardiovascular sys-
tem of PPS carriers is the performing of echocardiography 
and electrocardiographic in order to evaluate ventricular 
function, particularly left ventricle and electrical conduction. 
Stöllberger et al.36 described in a prospective observational 
study, an increased chance of patients with NMDs to evolve 
to left ventricular hypertrabeculation/noncompaction (LVHT) 
being the PPS carriers included in this group. Such condition 
may result in complex arrhythmias, besides, to predispose pa-
tients to sudden death, being in many cases asymptomatic.
It is believed that for the reduction of cardiovascular risk 
factors in subjects with PPS, it is necessary the guidance 
on changing habits such as nutritional education. In PPS a 
changeable and predominant risk factor to an increased 
chance of developing CHD is a sedentary lifestyle. Changes 
of the musculoskeletal system in PPS are the main factors for 
physical inactivity resulting in deconditioning, weight gain, 
changes in cholesterol and dyslipidemia37,38.
Additionally, Nollet et al.37 reported a significant re-
duction in aerobic capacity assessed by spirometry in PPS. 
This reduction causes limitation in performing activities in 
submaximal and maximal intensity which results in deteri-
oration of PSS functional capacity, becoming indicated the 
regular practice of physical exercise.
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Yet, Kriz et al.38 showed a significant improvement in in-
dividuals with PPS who participated in a 16-week exercise 
program with frequency of three times a week, with each 
session lasting 20 minutes using cycle ergometer of the up-
per limbs. The intensity of the activity was measured by re-
serve heart rate (70-75%) using the Karvonen formula and 
the Borg scale (13-15 points).
Doing so, all subjects underwent ergospirometric eval-
uation before and after the exercise program. At the end of 
20 weeks there was an increase in exercise time performed 
by the group that practiced the activity, besides an increase 
in VO2peak, VCO2 and VE in addition to the safety report re-
garding hemodynamics during the training session, thus prov-
ing the benefits of physical activity for people with PPS com-
pared with PSS carriers that do not practice any exercise38.
Besides, the study by Dean and Ross39 found that an ex-
ercise program for six weeks, at an intensity of 55-70% of 
maximum heart rate (assessed by average predictive for-
mula), three times a week, may play a significant role in 
improving endurance, reducing fatigue during the perfor-
mance of daily life activities.
Aiming the correct prescription of exercise intensity, 
Voorn et al. described that the anaerobic threshold can be 
obtained in individuals with PSS following with gold stan-
dard for such demand. However, the ergometer used must be 
the cycle ergometer. In case of the impossibility of obtaining 
the anaerobic threshold (no ergospirometer) the use of Borg 
scale seems to be the best alternative40.
In order to check cardiovascular risk in individuals with 
PPS, it is suggested the monitoring of the lipid profile, con-
ducting global scores and CAC. The performing of electro-
cardiogram and echocardiogram is essential so as to discard 
possible arrhythmic and/or ventricular dysfunction chang-
es. With regard to the exercise prescription, the results of 
the electrocardiogram and echocardiogram helped achieve 
proper stratification of pre-risk exercise, but the exercise 
tests must also be applied41.
Maximum testing should be avoided in PPS due to the 
fatigue that may be triggered and the activity should be pre-
scribed based on submaximal tests. The six-minute walk test 
despite being a submaximal intensity testing, has some lim-
itations because patients with PPS present biomechanical 
changes during the test performance and also because they 
are not able to undergo adjustments to its accomplishment41.
finAl remArks
The management of NMDs, including PPS poses a signif-
icant challenge for both clinicians and patients. Often this 
problem is complicated by “paradigm paralysis and cardio-
respiratory problems”, which leads clinicians to follow con-
ventional invasive protocols without considering noninva-
sive options and rehabilitation programs. Early detection and 
rehabilitation\clinical programs can have a management of 
such problems and prolongs quality of life.
The management of PPS requires new principles with 
specific attention to the factors of the vulnerability of com-
pensatory mechanisms to injury by overuse, underuse, under 
oxygenation, and an inefficient use of weakened muscula-
ture. Clinicians must provide information and a balanced 
prescription of exercise, rest, activity, support, and intelligent 
accommodation to additional disability. Further studies and 
other analysis are needed.
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